| |
| |
|
| Insider
Information: |
Jain Rita |
| Relationship: |
Chief Medical Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
225,697 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$129,085 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
225,697 |
|
|
| Total
Value |
$129,085 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akebia Therapeutics, Inc. |
AKBA |
SVP, Chief Medical Off... |
2019-04-11 |
96,332 |
2018-02-28 |
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
EVP, Chief Medical Off... |
2022-10-20 |
0 |
2019-05-23 |
0 |
Premium* |
|
|
Immunovant Inc |
IMVT |
Chief Medical Officer |
2021-03-19 |
129,365 |
2021-01-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCXI |
Chemocentryx, Inc. |
EVP, Chief Medical Officer |
• • – |
2022-10-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(35,863) |
0 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
EVP, Chief Medical Officer |
• • – |
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,726 |
35,863 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
EVP, Chief Medical Officer |
• • – |
2022-03-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,251 |
28,137 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2021-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,660 |
22,886 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2021-03-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,251 |
18,226 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2021-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
109,365 |
129,365 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Medical Officer |
• – – |
2021-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2020-03-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,251 |
12,975 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,724 |
7,724 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2019-04-11 |
4 |
D |
$7.70 |
$33,949 |
D/D |
(4,409) |
96,332 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
100,741 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2018-12-12 |
4 |
D |
$8.94 |
$77,411 |
D/D |
(8,659) |
20,741 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Medical Officer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
29,400 |
29,400 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
